BG
GWPH

Bellevue Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bellevue Group’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$2.17M – 229
2021
Q1 		$2.17M Sell
10,000
-462,389
-98% -$86.9M 0.02% 138
2020
Q4 		$54.5M Sell
472,389
-90,554
-16% -$10.1M 0.62% 49
2020
Q3 		$54.8M Buy
562,943
+213,377
+61% +$24.6M 0.76% 41
2020
Q2 		$42.9M Buy
349,566
+98,600
+39% +$11.2M 0.61% 44
2020
Q1 		$22M Buy
250,966
+239,766
+2,141% +$25.4M 0.43% 61
2019
Q4 		$1.17M Buy
11,200
+747
+7% +$83.8K 0.02% 149
2019
Q3 		$1.2M Sell
10,453
-1,900
-15% -$288K 0.02% 137
2019
Q2 		$2.13M Hold
12,353
– – 0.04% 128
2019
Q1 		$2.08M Buy
12,353
+5,924
+92% +$882K 0.11% 106
2018
Q4 		$626K Sell
6,429
-200
-3% -$26.2K 0.04% 127
2018
Q3 		$1.15M Sell
6,629
-550
-8% -$79.3K 0.07% 124
2018
Q2 		$1M Buy
7,179
+2,304
+47% +$327K 0.09% 120
2018
Q1 		$549K Sell
4,875
-75
-2% -$9.43K 0.05% 117
2017
Q4 		$653K Sell
4,950
-1,050
-18% -$123K 0.07% 118
2017
Q3 		$609K Hold
6,000
– – 0.06% 118
2017
Q2 		$602K Hold
6,000
– – 0.07% 122
2017
Q1 		$726K Hold
6,000
– – 0.1% 111
2016
Q4 		$670K Hold
6,000
– – 0.14% 101
2016
Q3 		$796K Buy
+6,000
New +$573K 0.14% 102

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Bellevue Group's GWPH Position: Q2 2021 in Review

Bellevue Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 10,000 shares — an estimated $2.17M sold.

Bellevue Group first reported a position in GWPH in Q3 2016 and held it in 19 quarters. The position peaked at $54.8M in Q3 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Bellevue Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Bellevue Group sold 10,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $2.17M.
  • Bellevue Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2016 and held it in 19 quarters.
  • Bellevue Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $54.8M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Bellevue Group's 13F filing for Q2 2021, filed 12 Aug 2021.